1. Home
  2. RA vs AUTL Comparison

RA vs AUTL Comparison

Compare RA & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RA
  • AUTL
  • Stock Information
  • Founded
  • RA 2016
  • AUTL 2014
  • Country
  • RA United States
  • AUTL United Kingdom
  • Employees
  • RA 1260
  • AUTL N/A
  • Industry
  • RA Investment Managers
  • AUTL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RA Finance
  • AUTL Health Care
  • Exchange
  • RA Nasdaq
  • AUTL Nasdaq
  • Market Cap
  • RA 711.7M
  • AUTL 625.4M
  • IPO Year
  • RA N/A
  • AUTL 2018
  • Fundamental
  • Price
  • RA $13.40
  • AUTL $1.38
  • Analyst Decision
  • RA
  • AUTL Strong Buy
  • Analyst Count
  • RA 0
  • AUTL 5
  • Target Price
  • RA N/A
  • AUTL $9.12
  • AVG Volume (30 Days)
  • RA 280.8K
  • AUTL 4.6M
  • Earning Date
  • RA 01-01-0001
  • AUTL 11-11-2025
  • Dividend Yield
  • RA 14.73%
  • AUTL N/A
  • EPS Growth
  • RA N/A
  • AUTL N/A
  • EPS
  • RA N/A
  • AUTL N/A
  • Revenue
  • RA N/A
  • AUTL $29,934,000.00
  • Revenue This Year
  • RA N/A
  • AUTL $634.25
  • Revenue Next Year
  • RA N/A
  • AUTL $93.16
  • P/E Ratio
  • RA N/A
  • AUTL N/A
  • Revenue Growth
  • RA N/A
  • AUTL 185.17
  • 52 Week Low
  • RA $11.89
  • AUTL $1.11
  • 52 Week High
  • RA $17.32
  • AUTL $5.00
  • Technical
  • Relative Strength Index (RSI)
  • RA 50.44
  • AUTL 28.28
  • Support Level
  • RA $13.45
  • AUTL $1.34
  • Resistance Level
  • RA $13.59
  • AUTL $1.46
  • Average True Range (ATR)
  • RA 0.08
  • AUTL 0.10
  • MACD
  • RA -0.01
  • AUTL 0.01
  • Stochastic Oscillator
  • RA 32.14
  • AUTL 11.11

About RA Brookfield Real Assets Income Fund Inc.

Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities. The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: